| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Revenue | $4K | -76.6% |
| Cost of Revenue | $2K | -69.1% |
| Gross Profit | $2K | -80.3% |
| R&D Expense | $4.4M | +52.4% |
| SG&A Expense | $4.0M | +15.4% |
| Operating Income | -$8.4M | -32.5% |
| Net Income | -$8.8M | -32.7% |
| EPS (Basic) | -$9.34 | +50.8% |
| EPS (Diluted) | -$9.34 |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.1M | -81.1% |
| Accounts Receivable | $4K | — |
| Inventory | $650K | +3.4% |
| Current Assets | $2.2M | -70.5% |
| Total Assets | $4.2M | -55.6% |
| Current Liabilities | $3.7M | +111.4% |
| Total Liabilities | $4.0M | +83.8% |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.4M | -22.1% |
| Capital Expenditures | $3K | -95.1% |
| Investing Cash Flow | -$30K | +75.9% |
| Financing Cash Flow | $2.7M | -73.6% |
| Free Cash Flow | -$7.4M | -20.9% |
| +50.8% |
| Stockholders' Equity |
| $205K |
| -97.2% |